Posted in | News | Gold

Roxgold Files NI 43-101 Technical Report for the Séguéla Gold Project

Roxgold Inc. (“Roxgold” or “the Company”) is pleased to announce today that it has filed the Feasibility Study NI 43-101 Technical Report on the Séguéla Gold Project in Côte d’Ivoire.

The report has an effective date of May 26, 2021 and is entitled “NI 43-101 Technical Report Séguéla Project, Feasibility Study, Worodougou Region, Côte d’Ivoire”. The results of the Feasibility Study were previously disclosed in the Company’s news release dated April 19, 2021, “Roxgold Announces Robust Séguéla Feasibility Study with After-Tax NPV of US$380 Million and 49% IRR.”

The Technical Report was prepared in accordance with the Canadian Securities Administrator’s National Instrument 43-101 – Standards of Disclosure for Mineral Projects; and is available for review under the Company’s profile on SEDAR at www.sedar.com and on the Company’s web site at www.roxgold.com.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Roxgold Inc.. (2021, May 28). Roxgold Files NI 43-101 Technical Report for the Séguéla Gold Project. AZoMining. Retrieved on June 18, 2024 from https://www.azomining.com/News.aspx?newsID=16629.

  • MLA

    Roxgold Inc.. "Roxgold Files NI 43-101 Technical Report for the Séguéla Gold Project". AZoMining. 18 June 2024. <https://www.azomining.com/News.aspx?newsID=16629>.

  • Chicago

    Roxgold Inc.. "Roxgold Files NI 43-101 Technical Report for the Séguéla Gold Project". AZoMining. https://www.azomining.com/News.aspx?newsID=16629. (accessed June 18, 2024).

  • Harvard

    Roxgold Inc.. 2021. Roxgold Files NI 43-101 Technical Report for the Séguéla Gold Project. AZoMining, viewed 18 June 2024, https://www.azomining.com/News.aspx?newsID=16629.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.